Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Daiichi Sankyo collaborates on e-patient AF resource

Will work with European platform People Who on new illness profile

Daiichi Sankyo atrial fibrillation People Who 

Daiichi Sankyo is collaborating with European e-patients platform People Who on a new atrial fibrillation (AF) resource.

The aim is to spread awareness of the condition in the UK and to offer online services that help improve the lives of those affected by AF in any way.

Specifically it will offer an online community that allows users to pose questions to fellow members and a qualified doctor; a magazine with treatments, prevention and research articles, plus patient stories; and a 'control' section, where patients can record the food they eat, medication they take and their readings or test results.

The target audience for the resource ranges from patients who have been diagnosed with AF, those caring for someone with the illness or people that want to find out more about AF.

The AF section on People Who's website adds to the range of conditions it already caters for, including Alzheimer's disease, psoriasis, diabetes and skin cancer.

People Who began in 2012 in Spain, where its industry partners include Novartis, Lilly AstraZeneca and Daiichi Sankyo.

Since then it expanded in 2014 to the UK and Italy - where it currently only works with Daiichi Sankyo, France and Germany - where its partners are Roche and Daiichi Sankyo in 2014.

In 2015 the company opened its online doors in the US and its future plans include dedicated sites for Mexico, Argentina, Colombia, Peru and Chile.

18th February 2016

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Skills in Healthcare

At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...

Latest intelligence

Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...

Infographics